HIV/AIDS

NEW & NOTEWORTHY

Loss of Coverage and Increased Premium Costs Could Disrupt Care for People With HIV, Which Could Have Serious Implications for Public Health

People with HIV may be particularly vulnerable to substantial health care costs, treatment interruption, and declining health if Congress doesn’t extend ACA enhanced premium tax credits by the end of this year, according to a new KFF brief. This analysis examines the impact of expiring tax credits on individuals and the Ryan White HIV/AIDS Program, a federal safety net program for those with low-to-moderate incomes, reaching over half of people with HIV in the U.S.

ending the hiv epidemic (ehe) initiative

Ending the HIV Epidemic Funding Tracker

This tracker provides up-to-date data on federal Ending the HIV Epidemic (EHE) funding, including an overview of funding mechanisms by year, agency, grant mechanism, and jurisdiction.

HIV in the U.S.

The HIV/AIDS Epidemic in the United States

This updated fact sheet provides the latest data on the U.S. HIV epidemic, including key trends over time, impact by region and population, and information on the U.S. government’s response.

HIV Testing in the United States

This fact sheet provides information on key HIV testing statistics, testing recommendations, insurance coverage of HIV testing, testing sites and policies, and types of tests available.

The Ryan White HIV/AIDS Program

This fact sheet provides an overview of the Ryan White Program, the largest HIV-specific federal grant program in the United States.

global hiv/aids epidemic

PEPFAR Policy Resource Hub

This hub brings together key U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) policy resources – from KFF, the U.S. government, and others – that can be used to inform policy discussions and research. More items will be added to the hub over time.

The Global HIV/AIDS Epidemic

This updated fact sheet provides the latest data on the global HIV/AIDS epidemic, including impact on affected and vulnerable populations, treatment and prevention efforts, and an overview of the U.S. and global responses to the epidemic.

Global HIV/AIDS Timeline

The Global HIV/AIDS Timeline is an ongoing reference tool for the many political, scientific, cultural, and community developments that have occurred over the history of the HIV/AIDS epidemic.

Subscribe to KFF Emails

Choose which emails are best for you.
Sign up here

Filter

81 - 90 of 669 Results

  • PrEP Access in the United States: The Role of Telehealth

    Issue Brief

    This brief provides an overview of the tele-PrEP landscape, including how PrEP services (e.g., consults, lab work, prescribing, and monitoring) are provided and factors that facilitate its provision as well as barriers that remain. It is based on in-depth interviews with representatives from the major national telehealth companies providing tele-PrEP and other select tele-PrEP programs.

  • People With HIV in Non-Medicaid Expansion States: Who Could Gain Coverage Eligibility Through Build Back Better or Future Expansion?

    Issue Brief

    In this analysis, we explore the implications of the Build Back Better Act's current coverage provisions for people with HIV in select non-expansion states. We estimate the size of the population that could gain eligibility as well as their socio-demographic characteristics, examine their affordability barriers and assess the potential impact on the Ryan White HIV/AIDS Program. We also explore what Medicaid expansion could mean in these non-expansion states for people with HIV.

  • HIV Policy Alignment with International Standards in PEPFAR Countries

    Issue Brief

    This issue brief assesses how the HIV policy landscapes in PEPFAR countries compare to international standards and recommendations. Additionally, we look at the HIV policy landscapes in PEPFAR countries as compared to peer countries. These comparisons are done at the overall, category, and policy indicator level.

  • Economic Impact of COVID-19 on PEPFAR Countries

    Issue Brief

    The COVID-19 has exacted a significant toll on the global economy. This new analysis looks at the economic impacts in PEPFAR countries finding that these countries generally fared worse than their economic and regional peers. In addition, the projected economic growth in these countries remains below pre-pandemic levels.

  • Assessing PEPFAR’s Impact: Analysis of Mortality in PEPFAR Countries

    Issue Brief

    As the PEPFAR program approaches its two-decade mark, this new analysis finds the program was associated with large declines in mortality in PEPFAR recipient countries since its creation in 2003, suggesting that future investments will continue to yield significant health impacts.

  • Key Issues and Questions for PEPFAR’s Future

    Issue Brief

    This brief explores key issues and poses questions regarding PEPFAR’s future, providing a roadmap for the major decisions ahead for the program. It identifies eight key, interrelated issues facing the administration, Congress, and other PEPFAR stakeholders.